Active ingredient
Dexmethylphenidate
110 finished FDA listings contain Dexmethylphenidate as their only active ingredient; 3 combination products also contain it.
FDA NDC Directory
- Ingredient names as written by FDA
- DEXMETHYLPHENIDATE, DEXMETHYLPHENIDATE HYDROCHLORIDE
- Dosage forms
- Capsule, Extended Release, Tablet
- Routes
- Oral
- Manufacturers / labelers
- 15
- Strengths listed
- 10 mg/1 · 15 mg/1 · 2.5 mg/1 · 20 mg/1 · 25 mg/1 · 30 mg/1 · 35 mg/1 · 40 mg/1 · 5 mg/1
- Brand names in FDA listings
- Dexmethylphenidate Hydrochloride Extended-Release, Focalin, Focalin Xr
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 352372
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 021278 | SANDOZ | 2001-11-13 | 3 |
| NDA 021802 | SANDOZ | 2005-05-26 | 20 |
| ANDA 078992 | PLATINUM | 2013-11-18 | 6 |
| ANDA 202731 | TEVA PHARMS USA | 2013-11-19 | 4 |
| ANDA 078908 | TEVA PHARMS USA | 2013-11-19 | 4 |
| ANDA 079108 | IMPAX LABS INC | 2013-11-21 | 5 |
| ANDA 201231 | SUN PHARM INDUSTRIES | 2015-09-24 | 3 |
| ANDA 204534 | NOVEL LABS INC | 2015-12-04 | 3 |
| ANDA 206931 | ABHAI LLC | 2015-12-04 | 3 |
| ANDA 207901 | TRIS PHARMA INC | 2016-08-26 | 9 |
| ANDA 202842 | PH HEALTH | 2016-11-30 | 17 |
| ANDA 203614 | IMPAX LABS INC | 2017-07-05 | 2 |
| ANDA 209211 | CEDIPROF INC | 2018-09-19 | 4 |
| ANDA 210279 | ADARE PHARMS INC | 2018-10-09 | 8 |
| ANDA 212631 | ALKEM LABS LTD | 2019-07-19 | 3 |
| ANDA 213813 | GRANULES | 2020-09-09 | 8 |
| ANDA 215523 | ASCENT PHARMS INC | 2021-12-08 | 8 |
Official labeling on DailyMed
- DEXMETHYLPHENIDATE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA, INC.] · version 25 · 2026-09-02
- DEXMETHYLPHENIDATE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [AMNEAL PHARMACEUTICALS OF NEW YORK LLC] · version 15 · 2026-05-04
- DEXMETHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE (DEXMETHYLPHENIDATE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK] · version 104 · 2026-04-02
- DEXMETHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE (DEXMETHYLPHENIDATE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK] · version 104 · 2026-04-02
- DEXMETHYLPHENIDATE HYDROCHLORIDE TABLET [BRYANT RANCH PREPACK] · version 101 · 2026-03-18
- DEXMETHYLPHENIDATE HYDROCHLORIDE TABLET [BRYANT RANCH PREPACK] · version 101 · 2026-03-18
- DEXMETHYLPHENIDATE HYDROCHLORIDE TABLET [NIVAGEN PHARMACEUTICALS, INC.] · version 2 · 2026-01-08
- DEXMETHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE (DEXMETHYLPHENIDATE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [PAR HEALTH USA, LLC] · version 22 · 2026-01-07
- DEXMETHYLPHENIDATE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [PAR HEALTH USA, LLC] · version 13 · 2025-12-25
- FOCALIN (DEXMETHYLPHENIDATE HYDROCHLORIDE) TABLET [SANDOZ INC] · version 2 · 2025-12-12
- DEXMETHYLPHENIDATE HYDROCHLORIDE TABLET [KVK-TECH, INC] · version 14 · 2025-11-25
- FOCALIN XR (DEXMETHYLPHENIDATE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [SANDOZ INC] · version 5 · 2025-11-18
Showing the 12 most recent of 40 labels.
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.